LATEST NEWS

Phase I study of hafnium oxide nanoparticles activated by Intensity Modulated Radiation Therapy (IMRT) as a new therapeutic option for elderly or frail HNSCC patients

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.